Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyMyelomaTeam Subscriber asked a question 💭
December 4, 2025
 · 
Be the first to react
Vitamin D and Myeloma: Benefits and Uses Read Article...
MyMyelomaTeam

What is smoldering myeloma and how does it differ from active myeloma?

Smoldering multiple myeloma (SMM) is a precancerous condition where you have abnormal plasma cells and elevated M protein levels, but without any symptoms or organ damage. It's sometimes called asymptomatic myeloma because you don't feel sick.

The key Show Full Answer

What is smoldering myeloma and how does it differ from active myeloma?

Smoldering multiple myeloma (SMM) is a precancerous condition where you have abnormal plasma cells and elevated M protein levels, but without any symptoms or organ damage. It's sometimes called asymptomatic myeloma because you don't feel sick.

The key differences between SMM and active myeloma include:

Smoldering Myeloma:
* No symptoms like bone pain, fatigue, or nausea
* No organ damage (kidneys, bones, blood counts are normal)
* Elevated plasma cells and M protein detected through testing
* Monitored regularly but may not require immediate treatment

Active Multiple Myeloma:
* Causes noticeable symptoms such as bone pain, tiredness, or trouble thinking
* Shows signs of organ damage including high calcium levels, kidney problems, anemia, or bone lesions
* Requires treatment with medications like chemotherapy, stem cell transplants, or other therapies

SMM has a higher risk of progressing to active myeloma, especially in the first five years after diagnosis (about 10% per year). This risk decreases over time to about 3% per year during years 5-10, and 1% per year after that.

Some people with high-risk SMM may benefit from early treatment to delay or prevent progression to active myeloma.

December 4, 2025

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Boston, MA

A MyMyelomaTeam Subscriber asked a question 💭